홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
CRBU
#3070
Caribou Biosciences, Inc. Common Stock
1.9
0
-1.55%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-1.55%
월간 변동
+21.79%
6달 변화
-5.94%
년간 변동율
+62.39%
이전 종가
1.9
3
Open
1.9
0
Bid
Ask
Low
1.9
0
High
1.9
0
양
25
마켓
주식
헬스케어
CRBU
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
60.66 M
61.3 M
90.31 M
93 M
—
Valuation ratios
Enterprise value
674.99 M
346.85 M
451.89 M
131.58 M
485.86 M
Price to earnings ratio
—
-4.03
-4.04
-0.96
-3.61
Price to sales ratio
—
29.02
11.92
14.37
58.57
Price to cash flow ratio
—
4.42
4.41
1.04
4.22
Price to book ratio
—
1.34
1.12
0.57
1.05
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.15
0.27
0.24
0.48
0.65
Return on equity %
0.17
0.33
0.28
0.59
0.84
Return on invested capital %
445.36
461.56
417.75
680.35
—
Gross margin %
100
100
100
100
400
Operating margin %
697.84
768.17
336.63
1 667.16
6 816.98
EBITDA margin %
—
—
—
—
—
Net margin %
697.26
717.79
296.05
1 491.95
6 690.03
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
15.15
9.25
11.97
7.16
26.99
Inventory turnover
—
—
—
—
—
Asset turnover
0.02
0.03
0.09
0.03
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
0
0
0
0
—
Long term debt to total equity ratio
0
0
0
0
—
Per share metrics
Operating cash flow per share
—
1.5
1.26
1.53
1.36
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
—
5.21
5.05
2.76
8.74
Net current asset value per share
—
4.28
4.59
2.43
8.51
Tangible book value per share
—
4.95
4.99
2.8
8.45
Working capital per share
—
3.82
4.21
2.09
7.25
Book value per share
—
4.95
4.99
2.8
8.45
뉴스
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates
Caribou Biosciences CLO, CRBU 주식 $13,598 상당 매도
Caribou Biosciences CLO sold $13,598 in CRBU stock
카리부 바이오사이언스 CTO, 616만원 상당 주식 매도
Caribou Biosciences CTO Kelly sells $6.1k in shares
Caribou Biosciences CMO, CRBU 주식 2.1천 달러 상당 매도
Caribou Biosciences CBO, 칸, 13,598달러 상당 주식 매도
Caribou Biosciences CMO sells $2.1k in CRBU stock
Khan, Caribou Biosciences CBO, sells $13598 in stock
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Beats Revenue Estimates
Genomics Stocks That Deserve a Place in Your Portfolio in 2026
Is Biohaven Ltd. (BHVN) Stock Outpacing Its Medical Peers This Year?